Home › Stocks › HRTX › All Fund Holders
HRTX — HERON THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 37 · Reported value held: $39.12M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 9.82M | $12.77M | 0.00% | Add |
| Point72 Asset Management history | Q1 2025 | 4.78M | $10.51M | 0.03% | Add |
| BlackRock Inc history | Q2 2026 | 10.55M | $4.50M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 4.27M | $1.82M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 4.07M | $1.74M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 3.00M | $1.28M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 2.35M | $1.01M | 0.00% | New |
| Norges Bank Investment Management history | Q4 2022 | 279.00K | $697.50K | 0.00% | New |
| AQR Capital Management history | Q2 2026 | 1.55M | $663.19K | 0.00% | Add |
| Wellington Management Group history | Q3 2025 | 525.77K | $662.48K | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 1.51M | $643.14K | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 1.33M | $567.54K | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 1.22M | $522.18K | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 1.22M | $519.61K | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 406.67K | $173.56K | 0.00% | Add |
| Franklin Resources history | Q1 2025 | 77.55K | $170.61K | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 395.84K | $168.94K | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 266.31K | $113.66K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 226.80K | $96.80K | 0.00% | Add |
| Janus Henderson Group history | Q1 2023 | 44.53K | $67.45K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 152.92K | $65.27K | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 120.44K | $51.40K | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 111.70K | $47.67K | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 108.37K | $46.16K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 96.30K | $41.41K | 0.00% | Add |
| Manulife Financial history | Q1 2026 | 45.99K | $36.80K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 75.67K | $32.95K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 74.94K | $31.98K | 0.00% | Add |
| Balyasny Asset Management history | Q1 2025 | 11.49K | $25.28K | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 47.10K | $20.10K | 0.00% | Reduce |
| Prudential Financial history | Q2 2026 | 23.50K | $10.03K | 0.00% | Hold |
| Legal & General Investment Management America history | Q2 2026 | 13.93K | $5.95K | 0.00% | Hold |
| Principal Global Investors history | Q2 2026 | 12.07K | $5.15K | 0.00% | New |
| Baillie Gifford & Co history | Q1 2023 | 308 | $465 | 0.00% | Hold |
| PNC Financial Services history | Q2 2025 | 173 | $358 | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 111.50K | $48 | 0.00% | Hold |
| Lazard Asset Management history | Q1 2025 | 13.81K | $30 | 0.00% | New |